Between-group differences did not reach statistical significance at any time point.
← all excerpts
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.
1
—
—